Both in Biotechnology
Halozyme Therapeutics vs ImmunityBio
Over the past year HALO returned +95.5% and IBRX returned +273.9%; their daily moves had a correlation of 0.01.
HALO +95.5% IBRX +273.9%Growth of $1, one year, split-adjusted
| Metric | HALO | IBRX |
|---|---|---|
| Price | $129.42 | $8.45 |
| Market cap | $14.69B | $8.96B |
| Today | +0.62% | +1.93% |
| 1 month | +18.0% | −12.8% |
| 6 months | +95.1% | +0.8% |
| Year to date | +92.3% | +326.8% |
| 1 year | +95.5% | +273.9% |
| Revenue growth (YoY) | +47.7% | +93.9% |
| Gross margin | 83.5% | 99.4% |
| Net margin | 47.8% | −449.6% |
| P/E (TTM) | 35.5× | — |
| Price / sales | 8.8× | 54.0× |
| Net cash | -$1.92B | -$57.7M |
| Dividend yield | — | — |
| Volatility (60d) | 27.8% | 68.5% |
| Short % of float | 12.4% | 31.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).